Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica.
The analysis of the antibody repertoire of patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) might identify target antigens of the autoimmune response with potential relevance to our understanding of the pathogenesis of the disease and to the development of serodiagnostic tests. To detect such antigens, we screened a cDNA library derived from normal human testis for antigens reacting with IgG antibodies in the 1 : 250 diluted sera of three patients with untreated GCA using SEREX, the serological identification of antigens by recombinant cDNA expression cloning. Of 100 000 clones screened with each serum, six, 28 and six clones, respectively, were positive, representing a total of 33 different antigens. Most of the antigens reacted only with the serum used for identification and/or at a similar frequency with normal control sera. However, lamin C and the nuclear antigen of 14 kD reacted specifically with 32% of GCA/PMR, but with none of the control sera, while human cytokeratin 15, mitochondrial cytochrome oxidase subunit II, and a new gene product were detected preferentially, but not exclusively by sera from GCA/PMR patients. We conclude that patients with GCA/PMR develop antibodies against a broad spectrum of human autoantigens. Antibodies against human lamin C, the nuclear autoantigen of 14 kD as well as human cytokeratin 15, mitochondrial cytochrome oxidase subunit II and the product of a new gene should be investigated further to determine their value as tools for the diagnosis and/or the definition of clinical subgroups of patients with GCA/PMR.
Schmits
R
R
Department of Medicine, Saarland University Medical School, Homburg, Germany.
Kubuschok
B
B
Schuster
S
S
Preuss
K-D
KD
Pfreundschuh
M
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000918:Antibody Specificity; D001323:Autoantibodies / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology*; D003599:Cytoskeleton / Q000276:immunology; D018076:DNA, Complementary / Q000235:genetics; D003576:Electron Transport Complex IV / Q000235:genetics / Q000276:immunology; D005260:Female; D013700:Giant Cell Arteritis / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007633:Keratins / Q000235:genetics / Q000276:immunology; D034904:Lamin Type A; D034882:Lamins; D008297:Male; D008875:Middle Aged; D009687:Nuclear Proteins / Q000235:genetics / Q000276:immunology; D011111:Polymyalgia Rheumatica / Q000276:immunology*; D021122:Protein Subunits; D013737:Testis
D001323:Autoantibodies; D001324:Autoantigens; D018076:DNA, Complementary; D007074:Immunoglobulin G; D034904:Lamin Type A; D034882:Lamins; D009687:Nuclear Proteins; D021122:Protein Subunits; C440308:lamin C; D007633:Keratins; D003576:Electron Transport Complex IV